Connect with us

Uncategorized

Pivot Pharmaceuticals Inc (OTCMKTS:PVOTF) Signs Agreement For The Acquisition Licensing Rights To Patented TriVair™

Published

on

The signing of an Option Agreement between Pivot Pharmaceuticals Inc (OTCMKTS:PVOTF) and IP Med Inc is targeted towards the acquisition of an exclusive worldwide license for Pulmonary Breath-Propelled Drug Delivery Systems™ and Trivair™ Nasal to facilitate the production of the Ready-To-Infuse-Cannabis (“RTIC”) cannabinoid products of the business guru.

State of affairs

The expiry of the option will be in a matter of about six months within which the company will make a determination of the compatibility with Pivot’s RTIC powder formulations. The evaluation might be completed anytime soon and from that point Pivot will decide whether or not it is need of the TriVair™ device.If interested, it will be compelled to be a part of the Definitive Licensing Agreement with IP Med.

TriVair™ Nasal device turned out to be the winner of an innovation award which is given on a yearly basis. And reports indicate it uses the natural breath of the body in carrying out its functions.It is about providing the best form of treatment for a devastating conditions such as insomnia, epilepsy and migraines.

TriVair™ Pulmonary device

One researcher while addressing a number of new reporters outlined that the device worked on the restoration of airways eventually witnessing immense success in the treatment of lungs. He added that such targeting could was applicable in the treatment of the wide range of the respiratory conditions as well as in fighting off respiratory infections.

In one of its latest statements, Pivot has disclosed about its plan to combineTriVair™ delivery system with its cutting edge technology in a bid to deliver the best care for consumers and patients in the various markets where the new law has been implemented.

Dr. Leonid Lurya together with his team are conducting tests to evaluate, modify and test formulations that would help attain the desirable size of particle that the device will be producing.

Handling female sexual dysfunction

The company is also considering women struggling with female sexual dysfunction.It has already set aside the required funds and it is optimistic a lot of women will be able to benefit from the move.

Dr. Wolfgang Renz who is the current Chief Medical Officer of Pivot opined, “Given that our topical delivery system has previously shown to be safe and well tolerated when administered intravaginally in a clinical trial setting, we believe that we can deliver cannibinoids to target female sexual dysfunction.”

The company is seeking to mobilize its resources to ensure that it sharpens its competitive edge in a market characterized by stiff competition.

*Past performance is not a predictor of future results. All investing involves risk of loss and individual investments may vary. The examples provided may not be representative of typical results. Your capital is at risk when you invest – you can lose some or all of your money. Never risk more than you can afford to lose.By submitting your information you agree to the terms of our Privacy Policy • Cancel Newsletter Any Time.This is a FREE service from Finacials Trend. Signing up for our FREE daily e-letter also entitles you to receive this report. We will NOT share your email address with anyone.

Uncategorized

American Battery Metals Corp (OTCMKTS: ABML) Clinches A 13.8 Acre Property Situated At Storey County, NV

Published

on

American Battery Metals Corp (OTCMKTS: ABML) bought a 13.8-acre property in the most significant industrial park worldwide – Tahoe Reno Industrial Center, situated at Storey County, NV. 

Utilizes advanced extraction technologies

It is an ideal location to establish the battery recycling plant of American Battery Metals. The company would use sophisticated extraction technologies to provide battery metals satisfying the high domestic demand. It is eco friendly.

It does not release toxins into the air besides preventing water pollution. Doug Cole, CEO of American Battery Metals, said the purchase of this property is an essential milestone in its quest to build a battery recycling pilot plant. 

The company has a talented team ready to design and manage storage and plant construction activities efficiently and cost-effectively.

After the city of Fernley approves the core and shell building permits and final mass grading permits, the company would commence site grading operations. 

Receives the nod for lithium-ion battery recycling plant

The Fernley City Council for CUP (Conditional Use Permit) approved the upcoming lithium-ion battery recycling plant on June 17, 2021. 

Earlier this month, City of FPC (Fernley Planning Commission) granted Conditional Use Permit. As a result, the company now inched closer to permitting and constructing a lithium-ion battery recycling pilot plant in Nevada’s Fernley.

Cole said the CUP by the Fernley City Council allows the company to construct its lithium battery recycling pilot plant. 

The pilot plant expects to boost the economy in Fernley and generate employment. It also ensures a secure supply of battery metals for domestic needs. 

The Fernley City Council’s CUP also confirms that the American Battery Metals pilot plant would satisfy the City’s Comprehensive Master Plan obligations to protect the general welfare, safety, and public health. 

Supports transition to electric mobility

On May 25, 2021, American Battery Metals entered a strategic alliance to establish centralized service operations to collect and recycle electric vehicle batteries. 

The new venture at Cicle EV ChargeParks satisfies high demand for battery metals. It also facilitates the transition of truck fleets and global automakers into electric mobility. In addition, the new venture solves renewable energy supply chain issues and facilitates the fastest-growing EV ecosystem. 

The partnership between Cicle ChargeParks and American Battery Metals creates a highly advanced and practical renewable energy technology solution.

*Past performance is not a predictor of future results. All investing involves risk of loss and individual investments may vary. The examples provided may not be representative of typical results. Your capital is at risk when you invest – you can lose some or all of your money. Never risk more than you can afford to lose.By submitting your information you agree to the terms of our Privacy Policy • Cancel Newsletter Any Time.This is a FREE service from Finacials Trend. Signing up for our FREE daily e-letter also entitles you to receive this report. We will NOT share your email address with anyone.
Continue Reading

Uncategorized

Nextleaf Solutions Ltd (OTCMKTS: OILFF) Bestowed U.S. Copyright

Published

on

Nextleaf Solutions Ltd (OTCMKTS: OILFF) has announced that the United States Patent and Trademark Office has granted the company a Copyright relating to the abstraction and refinement of THC and CBD.  

The company believes it has established defensible intellectual property around the most effective methods for creating THC and CBD concentrate at a scale within a controlled market. Nextleaf holds 15 U.S. Copyrights and has been issued over 80 copyrights internationally.

“Nextleaf has advanced patented technology that may advance upon the therapeutic possessions of a accepted creation that has been in usage for thousands of years,” said Paul Pedersen, CEO of Nextleaf. “With pharmacological companies starting to arrive the cannabinoid space, we trust Nextleaf’s heap of intellectual property related to the manufacture of novel psychoactive mixes will draw a lot of consideration.”

Appointment of CannDelta for Health Canada Dealer’s permit

Nextleaf has involved CannDelta Inc. with deference to its submission for a Health Canada Controlled Drugs and Substances Dealer’s permit. Upon application tender and sanction from Health Canada, the Dealer’s permit is projected to permit Nextleaf Labs to conduct a diversity of actions connecting to psilocybin and psilocin comprising R&D, IP progress, manufacture of base ingredient resources, workroom examination, as well as the trade and delivery of the materials to certified persons, including investigators and for its use in scientific trials.

Company launches Specialty Molecules Division 

Nextleaf has announced the unveiling of a Specialty Molecules Division to emphasize the growth and commercialization of novel psychoactive mixes. The division is reinforced by the company’s current intellectual property collection, counting the built-up of CBD-O-acetate and the newly announced U.S. patent for the mixture of THC-O-acetate.

Nextleaf anticipates announcing a future R&D and novelty contract with a significant strategic associate functioning in the cannabis or pharmacological space. The first emphasis of the Specialty Molecules Division is commercializing more multifaceted cannabinoid-based cures that may deliver a healing substitute to opioid-based medicines. 

Nextleaf proposes to mature healing produces from its intellectual property relating to the acetylation of cannabinoids. The company anticipates issuing adult-use products with THC-O-acetate, which has never been marketed under a permissible framework to the best of the company’s information.

*Past performance is not a predictor of future results. All investing involves risk of loss and individual investments may vary. The examples provided may not be representative of typical results. Your capital is at risk when you invest – you can lose some or all of your money. Never risk more than you can afford to lose.By submitting your information you agree to the terms of our Privacy Policy • Cancel Newsletter Any Time.This is a FREE service from Finacials Trend. Signing up for our FREE daily e-letter also entitles you to receive this report. We will NOT share your email address with anyone.
Continue Reading

Uncategorized

Puration Inc (OTCMKTS:PURA) And PAO Group (OTCMKTS:PAOG) Inks A Pact to Develop Cannabis Centric Applications Jointly

Published

on

Puration Inc (OTCMKTS:PURA) reached an agreement with PAO Group (OTCMKTS:PAOG) to develop cannabis-centric applications. As per the terms of the pact, PAO will distribute its common stock to the investors of Puration.

Puration shareholders will receive one share of PAO for each of their shares in Puration. FINRA is currently reviewing the share distribution to Puration shareholders. Both PAO and Puration are jointly working on the Farmersville brands project of Puration.

Hemp as an eco-friendly substitute

Puration is constructing a facility on a 70-acre plot with PAO’s help with a target to demonstratable and interactive education to highlight the benefits of hemp.  The company intends to show hemp as an eco-friendly alternative to the prevailing industrial services and products that damages the environment.

Hemp provides an environmentally sustainable substitute for lumber, textile, and plastic material sources. The demand for the textile industry across the world is valued at over $1 trillion.

The demand for wholesale lumber in the US alone is valued at $100 billion. Also, the overseas demand for plastic is more than $500 million. According to Puration, the industry has not fully understood the potential of hemp. As industries turn to eco-friendly alternatives, Puration sees an opportunity for hemp-based materials to safeguard the environment. Therefore, the company will utilize the Farmersville brand project to achieve its target. Puration intends to develop a cooperative network of hemp processors and producers to market services and products under the Farmersville Hemp brand.

The market for hemp-based products

Farmersville brand project, which stands on a 70-acre facility, will promote hemp-based product growth. The demand for hemp-derived products expects to surge to $15 billion by the year 2027. PAO also cooperates with Puration for managing indoor hemp growing facilities to produce pharmaceutical-grade products. The hemp brand strategy of Puration will benefit from the overall environmental initiative of Biden.

PAO to generate revenues from CBD

This year, PAO will generate revenues from the expansion of cannabidiol nutraceuticals. In the presentation, PAO provided details of its engagement with North American Cannabis Holdings, Inc, Puration, and Alkme Holdings, Inc.

*Past performance is not a predictor of future results. All investing involves risk of loss and individual investments may vary. The examples provided may not be representative of typical results. Your capital is at risk when you invest – you can lose some or all of your money. Never risk more than you can afford to lose.By submitting your information you agree to the terms of our Privacy Policy • Cancel Newsletter Any Time.This is a FREE service from Finacials Trend. Signing up for our FREE daily e-letter also entitles you to receive this report. We will NOT share your email address with anyone.
Continue Reading

Trending Stories